Indeed, C/EBPδ over-expression correlates with poor prognosis in glioblastoma [29]; it is required for efficient metastatic growth of mammary tumors [30], and drives proliferation and invasiveness of urothelial carcinoma cells, thereby driving metastatic disease leading to a reduced disease-specific survival [31]. The gene discussed is CEBPD; the disease is breast cancer.